Skip to content

Devora Bracha Leventhal, DO

NPI 1245790435ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· Baltimore, MD

Internal Medicine, Advanced Heart Failure and Transplant Cardiology (DO) in Baltimore, Maryland, licensed in MD and FL, with an NPI issued in March 2019. Part D covered 159 prescriptions written in 2024, 90% of them generic. Endotronix, Inc. was the largest of 6 companies reporting payments in 2025, $466.51 in all, mostly food and beverage.

Overview

NPI1245790435
StatusActive
Entity typeIndividual
CredentialDO
Sole proprietorNo
NPI issuedMar 22, 2019
Last updated in NPPESOct 3, 2026
Certified by providerOct 3, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (FL); Practitioner - Advanced Heart Failure and Transplant Cardiology (MD)

Part D prescriptions in 2024

Prescriptions (claims)159 · 209 30-day fills
Patients23
Total drug cost$17,020
Generic share90% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$466.51 · 10 payments from 6 companies
  • 2024$125.00 · 1 payment from 1 company

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$466.51 · 10 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Baltimore

All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Maryland →